Fluorodeoxyglucose-positron-emission tomography findings in mantle cell lymphoma

Clinical Lymphoma, Myeloma and Leukemia

Volumn 11, Issue 3, 2011, Pages 261-266

  Alavi, Abass ^a   Shrikanthan, Sankaran ^a   Aydin, Aysel ^a   Talanow, Roland ^a   Schuster, Stephen ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

FDG PET; Mantle cell lymphoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SCINTISCANNING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MALE; MANTLE CELL LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; CANCER STAGING; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING;

AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA, MANTLE-CELL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

EID: 80053374853     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2011.03.013     Document Type: Article

References (19)

1. F. Bosch, A. Lopez-Guillermo, and E. Campo Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors Cancer 82 1998 567 575 (Pubitemid 28112997)
2. F. Bertoni, E. Zucca, and F.E. Cotter Molecular basis of mantle cell lymphoma Br J Haematol 124 2004 130 140 (Pubitemid 38122184)
3. G. Lenz, M. Dreyling, and W. Hiddemann Mantle cell lymphoma: established therapeutic options and future directions Ann Hematol 83 2004 71 77 (Pubitemid 38159609)
4. D. Delbeke, W.H. Martin, and D.S. Morgan 2-deoxy-2-[F-18]fluoro-D-glucose imaging with positron emission tomography for initial staging of Hodgkin's disease and lymphoma Mol Imaging Biol 4 2002 105 114 (Pubitemid 34272715)
5. J.W. Friedberg, and V. Chengazi PET scans in the staging of lymphoma: current status Oncologist 8 2003 438 447 (Pubitemid 37238871)
6. C. Schiepers, J.E. Filmont, and J. Czernin PET for staging of Hodgkin's disease and non Hodgkin's lymphoma Eur J Nucl Med Mol Imaging 30 2003 S82 S88 (Pubitemid 36735765)
7. 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma J Nucl Med 44 2003 224 239
8. R. Elstrom, L. Guan, and G. Baker Utility of FDG-PET scanning in lymphoma by WHO classification Blood 101 2003 3875 3876 (Pubitemid 36857861)
9. J.W. Sam, M.S. Levine, and M.C. Farner Detection of small bowel involvement by mantle cell lymphoma on F-18 FDG positron emission tomography Clin Nucl Med 27 2002 330 333 (Pubitemid 34437671)
10. S.B. Losik, Y. Studentsova, and D. Margouleff Chemotherapy-induced pericarditis on F-18 FDG positron emission tomography scan Clin Nucl Med 28 2003 913 915 (Pubitemid 38281852)
11. H. Zhuang, M. Hickeson, and T.K. Chacko Incidental detection of colon cancer by FDG positron emission tomography in patients examined for pulmonary nodules Clin Nucl Med 27 2002 628 632 (Pubitemid 38295060)
12. 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma J Nucl Med 44 2003 1072 1074
13. I. Buchmann, M. Reinhardt, and K. Elsner 2-(fluorine-18)fluoro-2-deoxy-D- glucose positron emission tomography in the detection and staging of malignant lymphoma A bicenter trial Cancer 91 2001 889 899
14. A. Matthies, S.J. Schuster, and A. Alavi Staging and monitoring response to treatment in primary non-Hodgkin's lymphoma of bone marrow using (18)F-fluorodeoxyglucose positron emission tomography Clin Lymphoma 1 2001 303 307
15. F. Moog, M. Bangerter, and C.G. Diederichs Extranodal malignant lymphoma: detection with FDG PET versus CT Radiology 206 1998 475 481 (Pubitemid 28112964)
16. C. Bodet-Milin, C. Touzeau, and C. Leux Prognostic impact of (18)F-fluorodeoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group Eur J Nucl Med Mol Imaging 37 2010 1633 1642
17. M. Karam, A. Ata, and K. Irish FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome Nucl Med Commun 30 2009 770 778
18. L. Brepoels, S. Stroobants, and W. De Wever Positron emission tomography in mantle cell lymphoma Leuk Lymphoma 49 2008 1693 1701
19. 18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma Clin Lymphoma Myeloma 8 2008 159 165